ECGI Issues Shareholder Update Letter From the CEO
February 16, 2022 08:00 ET
|
ECGI Holdings, Inc.
LOS ANGELES, Feb. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – ECGI HOLDINGS INC. (OTC: ECGI) (“ECGI” or the “Company”), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company...
Grapefruit USA, Inc. Comments on the NFL’s Recent $1 Million Award to Study the Use of Cannabis and CBD to Manage Pain
February 08, 2022 06:00 ET
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
Green Nexus is the First Authorized United States Distributor of Barneys Farm Seeds
February 08, 2022 05:00 ET
|
Green Nexus
HOLLYWOOD, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Green Nexus is the first authorized United States distributor of Barneys Farm seeds, one of the world's most recognized, awarded, and reputable...
Dyadic Introduces Novel Method to Produce Synthetic Cannabinoids and Precursors Utilizing C1 Cell Line Production Platform and Patent Pending Process
January 20, 2022 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
Grapefruit USA, Inc. Announces NNCP Submission to Health Canada to Enable Canada-Wide Sale of Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream
January 20, 2022 06:00 ET
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
January 19, 2022 07:30 ET
|
InMed Pharmaceuticals Inc.
CBT is the first of several rare cannabinoid launches planned for the first half of 2022; includes CBDV and THCVExpands the Company’s rare cannabinoid product portfolio, which also includes...
Registration Now Open For Tribe Public’s Webinar Event "Addressing The Increasing Demand For Rare Cannabinoids" Featuring InMed’s Management Team On January 6, 2022
December 30, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the development, manufacturing and commercialization...
InMed Pharmaceuticals Announces Publication of Peer-Reviewed Article on the Use of CBN as a Potential Treatment for Glaucoma
December 20, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the development, manufacturing and commercialization...
Grapefruit USA, Inc. Announces Hourglass™ Time Release THC+CBD Delivery Cream Is Now Available on Blitzdirect.com Mobile Delivery Platform
December 08, 2021 06:00 ET
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premier California-based...
Cannabistry’s Four Proprietary Canna-Tech Platforms Solve Industry Pain Points
December 02, 2021 06:00 ET
|
Cannabistry
SANTA ROSA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Cannabistry, the cannabis leader in world-class Research & Development, trusted products and reliable brand names, has developed four...